Glasgow

Futó vizsgálatok

• Fut, nem toboroz

  A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

  NCT02489318· 3. fázis· Forrás

• Fut, nem toboroz

  An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

  NCT02531516· 3. fázis· Forrás

• Fut, nem toboroz

  An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT02257736· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

  NCT01946204· 3. fázis· Forrás

• Fut, nem toboroz

  A Long-term Extension Study of PCI-32765 (Ibrutinib)

  NCT01804686· 3. fázis· Forrás

• Toboroz

  Product Surveillance Registry

  NCT01524276· Forrás

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

  NCT01776840· 3. fázis· Forrás

• Lezárult

  A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

  NCT01712490· 3. fázis· Forrás